Fiduciary Alliance’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Sell
3,327
-316
-9% -$117K 0.09% 233
2026
Q1
$1.13M Sell
3,643
-163
-4% -$53.6K 0.07% 249
2025
Q4
$1.33M Sell
3,806
-148
-4% -$50K 0.09% 210
2025
Q3
$1.28M Sell
3,954
-686
-15% -$213K 0.09% 206
2025
Q2
$1.8M Buy
4,640
+2
+0% +$804 0.13% 150
2025
Q1
$2.02M Sell
4,638
-318
-6% -$128K 0.2% 111
2024
Q4
$1.83M Buy
4,956
+4,338
+702% +$1.82M 0.18% 115
2024
Q3
$321K Buy
618
+5
+0.8% +$2.67K 0.04% 199
2024
Q2
$329K Buy
613
+2
+0.3% +$1.06K 0.05% 156
2024
Q1
$315K Buy
611
+21
+4% +$10.4K 0.06% 152
2023
Q4
$278K Sell
590
-48
-8% -$22.2K 0.05% 152
2023
Q3
$278K Sell
638
-31
-5% -$14.1K 0.06% 142
2023
Q2
$297K Buy
669
+132
+25% +$60.9K 0.06% 129
2023
Q1
$247K Hold
537
0.06% 123
2022
Q4
$275K Buy
+537
New +$273K 0.07% 119

Other funds holding ELV

Fiduciary Alliance's ELV Position: Q2 2026 in Review

Fiduciary Alliance reduced its Elevance Health (ELV) stake by 8.7% in Q2 2026, selling an estimated $117K and leaving 3,327 shares worth $1.29M. The position accounts for 0.09% of the portfolio, ranked #233.

Fiduciary Alliance first reported a position in ELV in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.02M in Q1 2025. 261 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Fiduciary Alliance held 3,327 shares of Elevance Health worth $1.29M as of Q2 2026.
  • Fiduciary Alliance sold 316 Elevance Health shares in Q2 2026, an estimated $117K.
  • Elevance Health made up 0.09% of Fiduciary Alliance's portfolio in Q2 2026, its #233 holding.
  • Fiduciary Alliance first reported a position in Elevance Health in Q4 2022 and has held it in 15 quarters since.
  • Fiduciary Alliance's Elevance Health position peaked at $2.02M in Q1 2025.
  • 261 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.